Site Search

Search
Showing 1 - 10 of 10 results
About the CF Foundation | Drug Pipeline | Antibiotics
FDA Approves First New Inhaled Antibiotic for CF in More Than a Decade

CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality

Press Release |
| 4 min read
Antibiotics | Infection Prevention and Control | Social Life and Relationships
The Right Way to Stick Your Wife With a Needle

Learning to help my wife access her port is part of our shared journey with CF. Check out our video for some tips and tricks we’ve learned along the way.

Peter Frey
| 2 min read
Antibiotics | North American CF Conference | Infection Prevention and Control
What I Learned About Treating NTM at NACFC

Even though I haven't cultured for nontuberculous mycobacteria, I was excited to learn more about the treatment for the bacteria in people with cystic fibrosis during the virtual session at the North American Cystic Fibrosis Conference.

Meagan Helmick
| 3 min read
Antibiotics | Advocacy
CF Foundation Affirms Support of the Introduction of the PASTEUR Act

Proposed legislation has the potential to revitalize the global marketplace for novel antibiotics, bringing urgently needed medicines for drug-resistant infections to patients.

Press Release |
| 2 min read
Research | Antibiotics | About the CF Foundation
CF Foundation Awards Up to $3.3M to Polyphor for Inhaled Version of Antibiotic to Treat Pseudomonas

Today, the Cystic Fibrosis Foundation announced it has awarded up to $3.3 million to Polyphor AG to develop an inhaled version of murepavadin, an antibiotic that targets multi-drug resistant Pseudomonas aeruginosa infections in people with cystic fibrosis. About 17% of individuals with CF who had Pseudomonas infections last year had multi-drug resistant strains.

Press Release |
| 3 min read